17.816 articles found

Deltex 2 Mediates Oxidative Stress and Neurotoxicity in Freezing of Gait of Parkinson's Disease via the Notch2-Nrf2 Axis.

Zheng Q, Zheng X, Zhao J, Lin L, Chen Y, Wang H, Lin Z, Yu L.

CNS Neurosci Ther · 2026-09-01

DOI: 10.1002/cns.71135PMID: 42759523

Sex- and Laterality-Specific Associations Between Serum Uric Acid-to-Creatinine Ratio and Gait Parameters in Parkinson's Disease.

Guo H, Shao K, Bu Y, Li W, Hu J, Zhang Y, Li J.

Brain Behav · 2026-09-01

DOI: 10.1002/brb3.71737PMID: 42768858

Selective umami taste impairment in anosmic Parkinson's disease: associations with non-motor symptoms.

Yavuz Z, Önder H, Eldek FA, Çomoglu SS.

Ideggyogy Sz · 2026-09-01

DOI: 10.18071/isz.79.0315PMID: 42803097

Association of Fecal Calprotectin with Motor and Nonmotor Features in Idiopathic Parkinson's Disease and Atypical Parkinsonism.

Sharma A, Mehta S, Singh AK, Kumar R, Singh J, Chakravarty K, Lal V.

Ann Indian Acad Neurol · 2026-09-01

DOI: 10.4103/aian.aian_195_26PMID: 42867500

The <i>LRRK2</i> R1441G+M1646T haplotype is associated with slower motor symptom progression in Parkinson’s disease

Schumacher JG, Zhang X, Wang J, Chen X.

· 2026-08-31

DOI: 10.64898/2026.08.26.26361428

The LRRK2 R1441G+M1646T haplotype is associated with slower motor symptom progression in Parkinson’s disease

Check source for author details

medRxiv · 2026-08-31

VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Bentall LM, Parr-Brownlie LC.

Neuroscience · 2026-08-31

DOI: 10.1016/j.neuroscience.2026.08.050PMID: 42674206

Efficacy and Safety of Photobiomodulation Therapy for Motor Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Mariano J, Piña Mojica E, Soto-Rodríguez A, Gianlorenço AC, Pacheco-Barrios K, Fregni F.

Brain Sci · 2026-08-31

DOI: 10.3390/brainsci16090925PMID: 42793350

Pallidal beta oscillations underlying locomotor adaptation in Parkinson’s disease

Choi JT, Gurrala A, Wang DD, de Hemptinne C, Wong JK.

· 2026-08-28

DOI: 10.64898/2026.08.25.744491

Effects of Modafinil on Motor and Non-Motor Outcomes in Parkinson’s Disease: A Meta-Analysis and Systematic Review of Randomized, Placebo-Controlled Trials

Pitton Rissardo J, Thalla A, Chintharala K, Fornari Caprara AL.

· 2026-08-28

DOI: 10.20944/preprints202608.2136.v1

Hyperdirect projections from the supplementary motor area mediate subthalamic stimulation effects on movement initiation and inhibition in Parkinson's disease.

Meyer GM, Albares M, Lio G, Beliakova A, Polo G, Lau B, Horn A, Thobois S, Ballanger B, Boulinguez P.

Brain Commun · 2026-08-28

DOI: 10.1093/braincomms/fcag325PMID: 42846914

Problematic Smartphone Use in Parkinson's Disease: Associations with Mood, Non-Motor Burden, and Impulsivity.

Kuşoğlu M, Erdoğan M, Barut BÖ.

J Mov Disord · 2026-08-28

DOI: 10.14802/jmd.26203PMID: 42661271